Introduction: The Neuromodulation Appropriateness Consensus Committee (NACC) of the
International Neuromodulation Society (INS) evaluated evidence regarding the safety and …

A growing number of patients, particularly those with advanced, chronic coronary artery
disease, experience symptoms of angina that are refractory to treatment with β-blockers …

5. Leczenie.............................................................. 1225 5.1. Farmakoterapia
niedokrwienia...................... 1225 5.1. 1. Ogólne leczenie objawowe................. 1225 5.1. 2 …

Background Many patients with coronary artery disease who are not candidates for
revascularization have refractory angina despite standard medical therapy. The balloon …

Aims An increasing number of patients with severe coronary artery disease (CAD) are not
candidates for traditional revascularization and experience angina in spite of excellent …

Objectives: This study tested whether intramyocardial (IM) administration of mobilized,
purified autologous CD34+ cells would improve total exercise time (TET) and angina …

Abstract Aims Autologous CD34+ (auto-CD34+) cells represent an attractive option for the
treatment of refractory angina. Three double-blinded randomized trials (n= 304) compared …

In recent years, as the mechanisms of vasculogenesis and angiogenesis have been
uncovered, the functions of various pro-angiogenic growth factors (GFs) and cytokines have …

Background Clinical outcomes in patients with refractory angina (RA) are poorly
characterized and variably described. Using the Duke Database for Cardiovascular Disease …

Aim To systematically review currently available cardiac shock-wave therapy (CSWT)
studies in humans and perform meta-analysis regarding anti-anginal efficacy of CSWT …